C - Chemistry – Metallurgy – 07 – C
Patent
C - Chemistry, Metallurgy
07
C
C07C 279/18 (2006.01) A01N 37/52 (2006.01) A01N 43/42 (2006.01) A61K 31/155 (2006.01) A61K 31/44 (2006.01) C07D 219/08 (2006.01)
Patent
CA 2547972
Novel fused ring dicationic anti-protozoan compounds. Representative protozoan species include but are not limited to Trypanosoma brucei rhodesiense (T.b.r) and Plasmodium faciparum. Prodrugs of these compounds can be used as an oral treatment for malaria and human African trypanosomiasis.
La présente invention concerne de nouveaux composés antiprotozoaires dicationiques cycliques fusionnés. Les espèces protozoaires représentatives comprennent, mais sans limitation, Trypanosoma brucei rhodesiense (T.b.r) et Plasmodium faciparum. Les promédicaments de ces composés peuvent être utilisés en tant que traitement oral contre la malaria et la trypanosomiase africaine humaine.
Arafa Reem K.
Boykin David W.
Brun Reto
Stephens Chad E.
Tidwell Richard R.
Brun Reto
Georgia State University Research Foundation Inc.
Norton Rose Or S.e.n.c.r.l.,s.r.l./llp
University Of North Carolina At Chapel Hill
LandOfFree
Fused ring dicationic anti-protozoan agents and their prodrugs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fused ring dicationic anti-protozoan agents and their prodrugs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fused ring dicationic anti-protozoan agents and their prodrugs will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1754532